South Korea
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
51.61%
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
2 |
21.85%
|
Dec. 31, 2023 | USD 7.40 | 0.83% |
|
South Korea |
|
3 |
15.94%
|
Dec. 31, 2023 | USD 11.69 | 2.23% |
|
South Korea |
|
4 |
13.99%
|
March 31, 2024 | USD 1.22 | 1.14% |
|
South Korea |
|
5 |
11.42%
|
Dec. 31, 2023 | USD 4.46 | 2.14% |
|
South Korea |
|
6 |
10.11%
|
Dec. 31, 2023 | USD 698.37 | 1.93% |
|
South Korea |
|
7 |
9.71%
|
Dec. 31, 2023 | USD 5.07 | 0.47% |
|
South Korea |
|
8 |
8.95%
|
Dec. 31, 2023 | USD 1.83 | 0.74% |
|
South Korea |
|
9 |
8.81%
|
Dec. 31, 2023 | USD 19.95 | 0.05% |
|
South Korea |
|
10 |
8.79%
|
Dec. 31, 2023 | USD 38.12 | 0.02% |
|
South Korea |
|
11 |
8.70%
|
Dec. 31, 2023 | USD 14.32 | 2.94% |
|
South Korea |
|
12 |
7.26%
|
Dec. 31, 2023 | USD 11.90 | 0.22% |
|
South Korea |
|
13 |
7.16%
|
Dec. 31, 2023 | USD 8.54 | 0.34% |
|
South Korea |
|
14 |
6.81%
|
Dec. 31, 2023 | USD 1.81 | 1.70% |
|
South Korea |
|
15 |
6.61%
|
Dec. 31, 2023 | USD 5.79 | -4.44% |
|
South Korea |
|
16 |
6.03%
|
Dec. 31, 2023 | USD 24.38 | 0.88% |
|
South Korea |
|
17 |
5.68%
|
Dec. 31, 2023 | USD 7.36 | 1.21% |
|
South Korea |
|
18 |
5.63%
|
Dec. 31, 2023 | USD 7.15 | 4.63% |
|
South Korea |
|
19 |
5.06%
|
Dec. 31, 2023 | USD 68.20 | 0.14% |
|
South Korea |
|
20 |
4.98%
|
Dec. 31, 2023 | USD 61.65 | 0.74% |
|
South Korea |
|
21 |
4.83%
|
Dec. 31, 2023 | USD 16.30 | -3.69% |
|
South Korea |
|
22 |
3.97%
|
Dec. 31, 2023 | USD 125.83 | 1.12% |
|
South Korea |
|
23 |
3.57%
|
Dec. 31, 2023 | USD 83.61 | 0.82% |
|
South Korea |
|
24 |
2.74%
|
Dec. 31, 2023 | USD 7.70 | -1.01% |
|
South Korea |
|
25 |
2.53%
|
Dec. 31, 2023 | USD 10.90 | 0.42% |
|
South Korea |
|
26 |
2.33%
|
Dec. 31, 2023 | USD 36.83 | -2.69% |
|
South Korea |
|
27 |
1.91%
|
Dec. 31, 2023 | USD 108.37 | -2.33% |
|
South Korea |
|
28 |
1.09%
|
Dec. 31, 2023 | USD 1.73 | 1.34% |
|
South Korea |
|
29 |
0.51%
|
Dec. 31, 2023 | USD 12.88 | 0.37% |
|
South Korea |
|
30 |
0.51%
|
Dec. 31, 2023 | USD 33.55 | -1.07% |
|
South Korea |
|
31 |
0.24%
|
Dec. 31, 2023 | USD 2.84 | -1.97% |
|
South Korea |
|
32 |
0.14%
|
Dec. 31, 2023 | USD 17.02 | -2.20% |
|
South Korea |
|
33 |
-0.42%
|
Dec. 31, 2023 | USD 21.07 | 1.40% |
|
South Korea |
|
34 |
-0.91%
|
Dec. 31, 2023 | USD 13.36 | 2.04% |
|
South Korea |
|
35 |
-0.98%
|
Dec. 31, 2023 | USD 10.34 | -1.02% |
|
South Korea |
|
36 |
-1.86%
|
Dec. 31, 2023 | USD 209.72 | 3.60% |
|
South Korea |
|
37 |
-2.31%
|
Dec. 31, 2023 | USD 0.95 | -1.80% |
|
South Korea |
|
38 |
-4.70%
|
Dec. 31, 2023 | USD 1.03 | 0.60% |
|
South Korea |
|
39 |
-7.79%
|
Dec. 31, 2023 | USD 75.63 | -3.02% |
|
South Korea |
|
40 |
-8.33%
|
Dec. 31, 2023 | USD 4.09 | 4.76% |
|
South Korea |
|
41 |
-9.03%
|
Dec. 31, 2023 | USD 12.09 | 2.36% |
|
South Korea |
|
42 |
-9.84%
|
Dec. 31, 2023 | USD 15.31 | 0.29% |
|
South Korea |
|
43 |
-10.37%
|
Dec. 31, 2023 | USD 8.48 | -0.62% |
|
South Korea |
|
44 |
-11.20%
|
Dec. 31, 2023 | USD 7.85 | -1.23% |
|
South Korea |
|
45 |
-14.25%
|
Dec. 31, 2023 | USD 3.70 | 0.18% |
|
South Korea |
|
46 |
-14.31%
|
Dec. 31, 2023 | USD 10.57 | -0.48% |
|
South Korea |
|
47 |
-14.71%
|
Dec. 31, 2023 | USD 6.10 | 8.89% |
|
South Korea |
|
48 |
-19.30%
|
Dec. 31, 2023 | USD 3.90 | -0.31% |
|
South Korea |
|
49 |
-21.62%
|
Dec. 31, 2023 | USD 1.27 | -0.44% |
|
South Korea |
|
50 |
-24.52%
|
Dec. 31, 2023 | USD 1.63 | 0.95% |
|
South Korea |
The Biotechnology company in South Korea with the highest Return on Capital Employed (ROCE) is Osang Healthcare Co.,Ltd (KOSDAQ: 036220.KQ) at 51.61%.
The Biotechnology company in South Korea with the lowest Return on Capital Employed (ROCE) is Gencurix Inc. (KOSDAQ: 229000.KQ) at -109.25%.
The top 10 Biotechnology companies in South Korea by Return on Capital Employed (ROCE) are Osang Healthcare Co.,Ltd, JW Lifescience Corporation, Boditech Med Inc., ORIENT BIO Inc., Singsong Holdings Co.,Ltd., Samsung Biologics Co.,Ltd., JETEMA, Co., Ltd., EASY HOLDINGS Co., Ltd., Hanmi Science Co., Ltd. and Celltrion Pharm, Inc..
The bottom 10 Biotechnology companies in South Korea by Return on Capital Employed (ROCE) are Gencurix Inc., GeneOne Life Science, Inc., MedPacto, Inc., Helixmith Co., Ltd, PCL, Inc., Peptron, Inc., Oscotec Inc., Hyundai Bioscience Co., Ltd., Ildong Holdings Co., Ltd. and SillaJen, Inc..